当前位置: 首页 >> 检索结果
共有 4128 条符合本次的查询结果, 用时 2.1121187 秒

3701. Hypoglycaemia and human insulin.

作者: E A Gale.
来源: Lancet. 1989年2卷8674期1264-6页

3702. Stress ulcer prophylaxis in critically ill patients.

来源: Lancet. 1989年2卷8674期1255-6页

3703. Erythropoietin reaches the pharmacy.

来源: Lancet. 1989年2卷8674期1252-4页

3704. Oral hairy leucoplakia.

来源: Lancet. 1989年2卷8673期1194页

3705. Respiratory infection and sudden infant death.

来源: Lancet. 1989年2卷8673期1191-2页

3706. Chemotherapy and hepatitis B.

来源: Lancet. 1989年2卷8672期1136-7页

3707. Steroids and croup.

来源: Lancet. 1989年2卷8672期1134-6页

3708. ACE inhibitors after myocardial infarction.

来源: Lancet. 1989年2卷8672期1133-4页

3709. A neurogenic mechanism for symmetrical arthritis.

作者: B L Kidd.;P I Mapp.;S J Gibson.;J M Polak.;F O'Higgins.;J C Buckland-Wright.;D R Blake.
来源: Lancet. 1989年2卷8672期1128-30页
Human synovium is richly innervated by autonomic and sensory nerve fibres, many of which contain neuropeptides. The hypothesis is that, in addition to a sensory role, some of these fibres modulate the response of the synovial membrane to a variety of noxious stimuli by releasing these peptides. Synovial damage results in acute inflammation in the damaged joint and a neurogenically mediated infiltrate of inflammatory cells in the contralateral joint. These cells might protect the contralateral synovium from injury similar to that in the damaged joint. An increased response would lead to synovitis and symmetrical disease.

3710. Epidural block for Caesarean section and circulatory changes.

来源: Lancet. 1989年2卷8671期1076-8页

3711. Multidrug resistance in cancer.

来源: Lancet. 1989年2卷8671期1075-6页

3712. Are in-vitro fertilisation and embryo transfer of benefit to all?

作者: M G Wagner.;P A St Clair.
来源: Lancet. 1989年2卷8670期1027-30页
The efficacy, safety, costs, and benefits of in-vitro fertilisation and embryo transfer (IVF/ET) have been reviewed. IVF/ET benefits only a small proportion of infertile women, it is expensive, and has serious health risks. Therefore policies for the management of infertility in which most financial and manpower resources are applied to prevention of infertility must be developed. Health authorities should also require accreditation of IVF/ET programmes, certification of providers, and ongoing monitoring of clinics. Full and accurate information on IVF/ET must also be disseminated, so that individuals seeking treatment for infertility can make the best informed choice about their care and health authorities can decide the place of IVF/ET in their infertility services.

3713. Androgen blockade and suppression for prostate carcinoma.

来源: Lancet. 1989年2卷8670期1020页

3714. Airway obstruction during sleep in children.

来源: Lancet. 1989年2卷8670期1018-9页

3715. Oral iron chelators.

来源: Lancet. 1989年2卷8670期1016-7页

3716. Mumps meningitis and MMR vaccination.

来源: Lancet. 1989年2卷8670期1015-6页

3717. Prognostic factors in childhood rhabdomyosarcoma.

来源: Lancet. 1989年2卷8669期959-60页

3718. Abnormal blood clotting after head injury.

来源: Lancet. 1989年2卷8669期957-8页

3719. Tumour cell vaccines: has their time arrived.

来源: Lancet. 1989年2卷8669期955-7页

3720. DNA technology and rapid diagnosis of infection.

来源: Lancet. 1989年2卷8668期897-8页
共有 4128 条符合本次的查询结果, 用时 2.1121187 秒